KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 35/100 — a percentile rank of KESTRA MEDICAL TECHNOLOGIES, LTD.’s fundamentals against Manufacturing peers, weakest on management. A quality ranking, not a price prediction.
| Market cap | $1.7B |
| P / S | 15.8× |
| EV / EBITDA | -12.6× |
| Gross margin | 53.9% |
| Operating margin | -134.5% |
| Net margin | -140.4% |
| Return on equity | -67.4% |
| ROIC | -63.6% |
| Debt / equity | 0.3× |
| Dividend yield | 0.0% |
Independent of the events above — derived from KESTRA MEDICAL TECHNOLOGIES, LTD.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact